Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Cisplatin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 64 Squamous Cell Carcinoma of Head and Neck 35 Lung Neoplasms 30 Urinary Bladder Neoplasms 19 Oropharyngeal Neoplasms 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Nasopharyngeal Carcinoma 12 Carcinoma 12 Biliary Tract Neoplasms 12 Esophageal Squamous Cell Carcinoma 11 Ovarian Neoplasms 10 Head and Neck Neoplasms 10 Colorectal Neoplasms 10 Uterine Cervical Neoplasms 9 Neoplasm Metastasis 9 Laryngeal Neoplasms 9 Carcinoma, Squamous Cell 9 Mouth Neoplasms 8 Mesothelioma, Malignant 8 Esophageal Neoplasms 8 Carcinoma, Transitional Cell 8 Hypopharyngeal Neoplasms 7 Stomach Neoplasms 6 Cholangiocarcinoma 6 Neoplasms 5 Gallbladder Neoplasms 5 Pancreatic Neoplasms 4 Medulloblastoma 4 Fallopian Tube Neoplasms 4 Breast Neoplasms 4

Interventions

Cyclophosphamide 21 Rituximab 18 fludarabine 15 obinutuzumab 10 pirtobrutinib 9 fludarabine phosphate 9 venetoclax 8 ibrutinib 7 Prednisone 7 Lenalidomide 7 Biopsy 7 tocilizumab 6 glofitamab 6 Specimen Handling 6 Immunotherapy, Adoptive 6 polatuzumab vedotin 5 Mycophenolic Acid 5 Magnetic Resonance Spectroscopy 5 X-Rays 4 Tacrolimus 4 Phantoms, Imaging 4 Doxorubicin 4 pembrolizumab 3 palbociclib 3 olaparib 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 Vincristine 3 Vemurafenib 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06230224 2026-02-06

OLYMPIA-4

Regeneron Pharmaceuticals

Phase 3 Recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡